Search results
Analyst Report: Bristol-Myers Squibb Company
Morningstar Research via Yahoo Finance· 7 hours agoBristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where ...
Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Simply Wall St. via Yahoo Finance· 6 days agoKey Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price...
Does Bristol-Myers Squibb (NYSE:BMY) Have A Healthy Balance Sheet?
Simply Wall St. via Yahoo Finance· 17 hours agoWarren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to...
Hawaii court orders drug companies to pay $916 million in Plavix blood thinner lawsuit - The Boston...
The Boston Globe· 1 day agoA Hawaii court has ordered the manufacturers and distributors of the blood thinner Plavix to pay the...
Bristol Myers Squibb Announces 10-Year Strategy to Reach More Patients in Low- and Middle-Income...
Morningstar· 2 days agoThe Company enters strategic collaboration with the Access to Oncology Medicines (ATOM) Coalition to expand access to immuno-oncology therapy Opdivo™ in select countries PRINCETON, NJ / ACCESSWIRE ...
Pharmaceutical giants award $900M+ to state of Hawaii
KHON 2 Honolulu· 2 days agoHawaii has been awarded over $900 million against multiple pharmaceutical giants after they failed...
Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee...
Morningstar· 14 hours agoBALTIMORE, May 23, 2024 (GLOBE NEWSWIRE) -- Lawsuits have been filed alleging that a number of large corporate employers have offloaded billions of dollars in pension obligations to Athene Annuity ...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 2 days agoNeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb PR Newswire LONDON, May 22, 2024 Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression
Boston radiopharmaceuticals startup inks deal worth up to $1.16B with Lilly - Boston Business...
The Business Journals· 3 days agoA Boston radiopharmaceuticals startup that is already backed by three Big Pharma companies now has a...
